166 related articles for article (PubMed ID: 27783056)
1. Metabolic Response to XD14 Treatment in Human Breast Cancer Cell Line MCF-7.
Pan D; Kather M; Willmann L; Schlimpert M; Bauer C; Lagies S; Schmidtkunz K; Eisenhardt SU; Jung M; Günther S; Kammerer B
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783056
[TBL] [Abstract][Full Text] [Related]
2. Enantioselective Effects of Metalaxyl Enantiomers on Breast Cancer Cells Metabolic Profiling Using HPLC-QTOF-Based Metabolomics.
Zhang P; Zhu W; Wang D; Yan J; Wang Y; He L
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28085117
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling reveals sphingosine-1-phosphate kinase 2 and lyase as key targets of (phyto-) estrogen action in the breast cancer cell line MCF-7 and not in MCF-12A.
Engel N; Lisec J; Piechulla B; Nebe B
PLoS One; 2012; 7(10):e47833. PubMed ID: 23112854
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic analysis with GC-MS to reveal potential metabolites and biological pathways involved in Pb &Cd stress response of radish roots.
Wang Y; Xu L; Shen H; Wang J; Liu W; Zhu X; Wang R; Sun X; Liu L
Sci Rep; 2015 Dec; 5():18296. PubMed ID: 26673153
[TBL] [Abstract][Full Text] [Related]
5. Effects of glaucocalyxin A on human liver cancer cells as revealed by GC/MS- and LC/MS-based metabolic profiling.
Liu Y; Lu S; Zhao L; Dong X; Zhu Z; Jin Y; Chen H; Lu F; Hong Z; Chai Y
Anal Bioanal Chem; 2018 May; 410(14):3325-3335. PubMed ID: 29651531
[TBL] [Abstract][Full Text] [Related]
6. [Mechanism research on the lupeol treatment on MCF-7 breast cancer cells based on cell metabonomics].
Shi D; Kuang Y; Wang G; Peng Z; Wang Y; Yan C
Se Pu; 2014 Mar; 32(3):278-83. PubMed ID: 24984468
[TBL] [Abstract][Full Text] [Related]
7. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
8. GC-TOF/MS-based metabolomics approach to study the cellular immunotoxicity of deoxynivalenol on murine macrophage ANA-1 cells.
Ji J; Sun J; Pi F; Zhang S; Sun C; Wang X; Zhang Y; Sun X
Chem Biol Interact; 2016 Aug; 256():94-101. PubMed ID: 27350164
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic study of natrin-induced apoptosis in SMMC-7721 hepatocellular carcinoma cells by ultra-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry.
Lu S; Lu R; Song H; Wu J; Liu X; Zhou X; Yang J; Zhang H; Tang C; Guo H; Hu J; Mao G; Lin H; Su Z; Zheng H
Int J Biol Macromol; 2019 Mar; 124():1264-1273. PubMed ID: 30508545
[TBL] [Abstract][Full Text] [Related]
10. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
[TBL] [Abstract][Full Text] [Related]
11. Study on chemical constituents of herbal formula Er Miao Wan and GC-MS based metabolomics approach to evaluate its therapeutic effects on hyperuricemic rats.
Huang B; Hu X; Wang J; Li P; Chen J
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1118-1119():101-108. PubMed ID: 31030102
[TBL] [Abstract][Full Text] [Related]
12. [Mechanism research of curcumin on cancer cells based on cell metabolic profiling].
Hu JH; Xu PP; Hou LJ; Liu M; Wang H; Gao GH; Sun LX
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2359-2366. PubMed ID: 31359664
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry-based metabolic profiling of gemcitabine-sensitive and gemcitabine-resistant pancreatic cancer cells.
Fujimura Y; Ikenaga N; Ohuchida K; Setoyama D; Irie M; Miura D; Wariishi H; Murata M; Mizumoto K; Hashizume M; Tanaka M
Pancreas; 2014 Mar; 43(2):311-8. PubMed ID: 24518513
[TBL] [Abstract][Full Text] [Related]
14. Human Melanoma-Cell Metabolic Profiling: Identification of Novel Biomarkers Indicating Metastasis.
Kosmopoulou M; Giannopoulou AF; Iliou A; Benaki D; Panagiotakis A; Velentzas AD; Konstantakou EG; Papassideri IS; Mikros E; Stravopodis DJ; Gikas E
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244549
[TBL] [Abstract][Full Text] [Related]
15. Metabolic profiling of breast cancer: Differences in central metabolism between subtypes of breast cancer cell lines.
Willmann L; Schlimpert M; Halbach S; Erbes T; Stickeler E; Kammerer B
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():95-104. PubMed ID: 26218769
[TBL] [Abstract][Full Text] [Related]
16. Fecal Metabolic Profiling of Breast Cancer Patients during Neoadjuvant Chemotherapy Reveals Potential Biomarkers.
Zidi O; Souai N; Raies H; Ben Ayed F; Mezlini A; Mezrioui S; Tranchida F; Sabatier JM; Mosbah A; Cherif A; Shintu L; Kouidhi S
Molecules; 2021 Apr; 26(8):. PubMed ID: 33919750
[TBL] [Abstract][Full Text] [Related]
17. GC-MS based comparative metabolomic analysis of MCF-7 and MDA-MB-231 cancer cells treated with Tamoxifen and/or Paclitaxel.
Semreen MH; Alniss H; Cacciatore S; El-Awady R; Mousa M; Almehdi AM; El-Huneidi W; Zerbini L; Soares NC
J Proteomics; 2020 Aug; 225():103875. PubMed ID: 32534214
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiling of Lactococcus lactis under different culture conditions.
Azizan KA; Baharum SN; Mohd Noor N
Molecules; 2012 Jul; 17(7):8022-36. PubMed ID: 22759915
[TBL] [Abstract][Full Text] [Related]
19. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
